Stockscreener 앱 받기
2.06
8.85%
-0.20
시장 영업 전:
2.07
0.010
+0.49%
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
Geode Capital Management LLC Acquires 284,047 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World
Barclays PLC Buys 31,331 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World
FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by State Street Corp - Defense World
FibroBiologics Secures Second Tranche of $5 Million Financing - Defense World
FibroBiologics Announces $25 Million Financing - citybiz
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing - GlobeNewswire
FibroBiologics Secures Second $5M Tranche of $25M Equity Purchase Agreement with Yorkville Advisors - StockTitan
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - The Manila Times
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - GlobeNewswire Inc.
FibroBiologics (NASDAQ:FBLG) Receives Buy Rating from D. Boral Capital - Defense World
D. Boral Capital Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG) - MarketBeat
**FibroBiologics Enters Standby Equity Purchase Agreement for $25 Million Financing** ** - Defense World
FibroBiologics announces $25 million financing - MSN
FibroBiologics, Inc. announced that it expects to receive $15 million in funding from Yorkville Advisors Global LP - Marketscreener.com
FibroBiologics secures $25 million equity deal with Yorkville - Investing.com
FibroBiologics Secures $25M Equity Agreement for Trials - TipRanks
FibroBiologics Secures $25M Financing Deal to Advance Clinical Trials in Diabetic Foot Ulcers, Psoriasis - StockTitan
FibroBiologics finalizes agreement and terminates warrant By Investing.com - Investing.com Canada
FibroBiologics finalizes agreement and terminates warrant - Investing.com
Ionq Inc (IONQ-N) QuotePress Release - The Globe and Mail
FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Update - MarketBeat
Rodman & Renshaw Initiates Coverage of FibroBiologics (FBLG) with Buy Recommendation - MSN
FibroBiologics (NASDAQ:FBLG) Coverage Initiated at Rodman & Renshaw - MarketBeat
FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Up 7.2% in November - MarketBeat
FBLG: On Target to Initiate Phase 1/2 Trial in 2025… - MSN
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly - GlobeNewswire
FibroBiologics seeks patent for spleen disorder treatment By Investing.com - Investing.com Australia
FibroBiologics seeks patent for spleen disorder treatment - Investing.com India
FibroBiologics Files Patent for Breakthrough Splenomegaly Cell Therapy Treatment | FBLG Stock News - StockTitan
HC Wainwright Expects Stronger Earnings for FibroBiologics - MarketBeat
HC Wainwright Reaffirms Buy Rating for FibroBiologics (NASDAQ:FBLG) - Defense World
Fibrobiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction in Cell-Based Therapeutics - Marketscreener.com
FibroBiologics files patent for reducing cell therapy risks - Investing.com
FibroBiologics seeks patent for clot-prevention method - Investing.com
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics - GlobeNewswire
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with ... - The Bakersfield Californian
FibroBiologics Files Patent for Breakthrough Cell Therapy Blood Clotting Prevention | FBLG Stock News - StockTitan
Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
FibroBiologics files patent for reducing cell therapy risks By Investing.com - Investing.com Nigeria
FibroBiologics' (FBLG) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics Reports Wider Q3 Loss, Advances Clinical Pipeline Amid R&D Push | FBLG Stock News - StockTitan
FibroBiologics Inc. (FBLG) Quarterly 10-Q Report - Quartz
FBLGFibroBiologics, Inc. Latest Stock News & Market Updates - StockTitan
HC Wainwright Begins Coverage on FibroBiologics (NASDAQ:FBLG) - Defense World
HC Wainwright Forecasts FibroBiologics Q3 Earnings - MarketBeat
H.C. Wainwright sets stock target on FibroBiologics shares, cites portfolio By Investing.com - Investing.com Australia
FibroBiologics (NASDAQ:FBLG) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
FibroBiologics names interim CFO as Mark Andersen steps down By Investing.com - Investing.com Australia
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday - Benzinga
FibroBiologics CFO Andersen Resigns - MarketWatch
FibroBiologics names interim CFO as Mark Andersen steps down - Investing.com India
FibroBiologics reports breakthrough in artificial thymus research - Investing.com
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology - GlobeNewswire
FibroBiologics, Inc. Announces Updates for Novel Artificial Thymus Organoid Technology - Marketscreener.com
0.08%
0.05%
자본화:
|
볼륨(24시간):